target audience: TECH BUYER Publication date: Dec 2023 - Document type: IDC MarketScape - Doc Document number: # US49950023
IDC MarketScape: Worldwide Life Science R&D Strategic Consulting Services 2023 Vendor Assessment
Content
List of Tables
List of Figures
Get More
When you purchase this document, the purchase price can be applied to the cost of an annual subscription, giving you access to more research for your investment.
Related Links
Abstract
This IDC Health Insights study is a refresher of the life science R&D IDC MarketScape, which has a specific focus on strategic consulting in the life science R&D space. This document seeks to compare major service providers with each other based on criteria that should be important to life science companies when considering the selection of a strategic consulting partner to help provide guidance for strategic, operational, and tactical transformation issues within the R&D space. The IDC MarketScape assessment of strategic consulting outsourcing in life science R&D was previously performed in 2011, 2014, 2016, 2018, and 2021.
Dr. Nimita Limaye, research VP, Life Science R&D Strategy and Technology, IDC, notes, "Ongoing disruption, led by a pandemic, geopolitical turmoil, a recession, and the generative AI wave, have all resulted in a lot of uncertainty for the life sciences industry. As companies try to define the right strategy to forge ahead, they are trying to outline their digital transformation strategy, identify top priority use cases to guide their near-term and long-term IT investment road maps, and revamp their product portfolios while never losing focus on quality, risk, and compliance. The life sciences industry is leaning on its strategic consulting partners to lead the way and prepare their organizations to build digital resiliency and scale growth and innovation in a fast evolving, yet fluid world powered by 'AI everywhere.'"